Stay Updated
Press Releases
ICYMI: Patients On Medicare Celebrate $2,000 Cap On Out-Of-Pocket Costs
Millions Of Patients Anticipate Substantial Savings As New Limit On Annual Out-of-Pocket Costs Goes Into Effect January 1st WASHINGTON, D.C. — Starting this week, everyone with Medicare Part D will have their annual out-of-pocket drug costscappedat $2,000. This historic reform is one of the most substantial provisions from the 2022 prescription drug price law to […]
Press Releases
Patients For Affordable Drugs Continues to Fight Against Big Pharma’s Attempts to Undermine Medicare Drug Price Negotiation at the Expense of Patients WASHINGTON D.C. — Patients For Affordable Drugs filed a 29-page amicus brief today in the U.S. Court of Appeals for the Third Circuit, defending Medicare’s authority to negotiate lower drug prices in a […]
Press Releases
Patients For Affordable Drugs Continues to Fight Against Big Pharma’s Attempts to Undermine Medicare Drug Price Negotiation at the Expense of Patients WASHINGTON D.C. — Oral arguments were heard today by the United States Court of Appeals for the Third Circuit in the consolidated cases brought by Bristol Myers-Squibb (BMS), AstraZeneca, and Janssen Pharmaceuticals challenging […]
Press Releases
Judge Upholds Medicare’s Drug Price Negotiation Program, Dealing Another Blow to Pharmaceutical Industry Lawsuits WASHINGTON D.C. — Marking the eighth win in the ongoing legal battle to preserve the Medicare Negotiation Program, on Friday, October 18th, a district court judge in New Jersey rejected Novartis’ lawsuit against the drug price negotiation program. This ruling adds […]
Press Releases
NBC News Reports Soaring Medication Costs Force Patients Of Color To Make Impossible Choices WASHINGTON D.C. — Patients For Affordable Drugs released new findings today that spotlight five cancer medications with excessive price increases in July – four of which had already been hiked in January this year. Price increases on these drugs, which are […]
Press Releases
District Court Will Now Hear A Suit On The Merits–Like The Industry Has Lost In Every Other Jurisdiction WASHINGTON D.C. — Today, the U.S. Court of Appeals for the Fifth Circuit ruled that the National Infusion Center Association (NICA) — which is backed by the pharmaceutical lobbying group The Pharmaceutical Research and Manufacturers of America (PhRMA) […]
Press Releases
P4AD Counters Industry’s Legal Arguments, Recounts The Sordid History Of Big Pharma’s Opposition To Medicare Negotiation And Tells The Court Of The IRA’s Positive Impact On Millions Of Patients WASHINGTON D.C. — Patients For Affordable Drugs today filed a 30-page amicus brief in the Third Circuit Court of Appeals in cases brought by pharmaceutical giants […]
Press Releases
WASHINGTON D.C. — Today marks the second anniversary of President Biden signing the Inflation Reduction Act into law, a historic reform and monumental victory for the millions of Americans who depend on Medicare for their essential medications. Throughout the week, Patients For Affordable Drugs patient advocates participated in events celebrating different provisions of the drug […]